SCL-ometajući proteinski lokus jest protein koji je kod ljudi kodiran genom STIL sa hromosoma 1 .[ 5] [ 6]
Dužina polipeptidnog lanca je 1.287 aminokiselina , a molekulska težina 142.955 Da .[ 7]
10 20 30 40 50
MEPIYPFARP QMNTRFPSSR MVPFHFPPSK CALWNPTPTG DFIYLHLSYY
RNPKLVVTEK TIRLAYRHAK QNKKNSSCFL LGSLTADEDE EGVTLTVDRF
DPGREVPECL EITPTASLPG DFLIPCKVHT QELCSREMIV HSVDDFSSAL
KALQCHICSK DSLDCGKLLS LRVHITSRES LDSVEFDLHW AAVTLANNFK
CTPVKPIPII PTALARNLSS NLNISQVQGT YKYGYLTMDE TRKLLLLLES
DPKVYSLPLV GIWLSGITHI YSPQVWACCL RYIFNSSVQE RVFSESGNFI
IVLYSMTHKE PEFYECFPCD GKIPDFRFQL LTSKETLHLF KNVEPPDKNP
IRCELSAESQ NAETEFFSKA SKNFSIKRSS QKLSSGKMPI HDHDSGVEDE
DFSPRPIPSP HPVSQKISKI QPSVPELSLV LDGNFIESNP LPTPLEMVNN
ENPPLINHLE HLKPLQPQLY DEKHSPEVEA GEPSLRGIPN QLNQDKPALL
RHCKVRQPPA YKKGNPHTRN SIKPSSHNGP SHDIFEKLQT VSAGNVQNEE
YPIRPSTLNS RQSSLAPQSQ PHDFVFSPHN SGRPMELQIP TPPLPSYCST
NVCRCCQHHS HIQYSPLNSW QGANTVGSIQ DVQSEALQKH SLFHPSGCPA
LYCNAFCSSS SPIALRPQGD MGSCSPHSNI EPSPVARPPS HMDLCNPQPC
TVCMHTPKTE SDNGMMGLSP DAYRFLTEQD RQLRLLQAQI QRLLEAQSLM
PCSPKTTAVE DTVQAGRQME LVSVEAQSSP GLHMRKGVSI AVSTGASLFW
NAAGEDQEPD SQMKQDDTKI SSEDMNFSVD INNEVTSLPG SASSLKAVDI
PSFEESNIAV EEEFNQPLSV SNSSLVVRKE PDVPVFFPSG QLAESVSMCL
QTGPTGGASN NSETSEEPKI EHVMQPLLHQ PSDNQKIYQD LLGQVNHLLN
SSSKETEQPS TKAVIISHEC TRTQNVYHTK KKTHHSRLVD KDCVLNATLK
QLRSLGVKID SPTKVKKNAH NVDHASVLAC ISPEAVISGL NCMSFANVGM
SGLSPNGVDL SMEANAIALK YLNENQLSQL SVTRSNQNNC DPFSLLHINT
DRSTVGLSLI SPNNMSFATK KYMKRYGLLQ SSDNSEDEEE PPDNADSKSE
YLLNQNLRSI PEQLGGQKEP SKNDHEIINC SNCESVGTNA DTPVLRNITN
EVLQTKAKQQ LTEKPAFLVK NLKPSPAVNL RTGKAEFTQH PEKENEGDIT
IFPESLQPSE TLKQMNSMNS VGTFLDVKRL RQLPKLF
Ovaj gen kodira citoplazmatski protein uključen u regulaciju kontrolne tačke mitotskog vretena , regulatorni put koji prati segregaciju hromozoma tokom ćelijske diobe kako bi se osigurala pravilna distribucija hromosoma u ćeliji kćeri. Protein je fosforiliran u mitozi i kao odgovor na aktivaciju kontrolne tačke vretena i nestaje kada ćelije pređu u G-fazu . Stupa u interakciju sa mitotskim regulatorom , a njegova ekspresija je potrebna za efikasno aktiviranje kontrolne tačke vretena.
Predlaže se da se regulira aktivnost Cdc2 kinaze tokom zaustavljanja kontrolne tačke vretena. Hromosomske delecije koje spajaju ovaj gen i susjedni lokus obično se javljaju u T-ćelijskoj leukemiji , a smatra se da nastaju nelegitimnim događajima rekombinacije. Za ovaj gen pronađene su višestruke varijante transkripta koje kodiraju različite izoforme .[ 6]
Homozigotne mutacije u STIL genu uzrokuju primarnu mikrocefaliju (mali mozak ) kod ljudi.
^ a b c GRCh38: Ensembl release 89: ENSG00000123473 - Ensembl , maj 2017
^ a b c GRCm38: Ensembl release 89: ENSMUSG00000028718 - Ensembl , maj 2017
^ "Human PubMed Reference:" . National Center for Biotechnology Information, U.S. National Library of Medicine .
^ "Mouse PubMed Reference:" . National Center for Biotechnology Information, U.S. National Library of Medicine .
^ Brown L, Cheng JT, Chen Q, Siciliano MJ, Crist W, Buchanan G, Baer R (Nov 1990). "Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia" . EMBO J . 9 (10): 3343–51. doi :10.1002/j.1460-2075.1990.tb07535.x . PMC 552072 . PMID 2209547 .
^ a b "Entrez Gene: STIL SCL/TAL1 interrupting locus" .
^ "UniProt, Q15468" (jezik: eng.). Pristupljeno 5. 12. 2021 .CS1 održavanje: nepoznati jezik (link )
Aplan PD, Lombardi DP, Reaman GH, et al. (1992). "Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia" . Blood . 79 (5): 1327–33. doi :10.1182/blood.V79.5.1327.1327 . PMID 1311214 .
Aplan PD, Lombardi DP, Kirsch IR (1991). "Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia" . Mol. Cell. Biol . 11 (11): 5462–9. doi :10.1128/MCB.11.11.5462 . PMC 361915 . PMID 1922059 .
Jonsson OG, Kitchens RL, Baer RJ, et al. (1991). "Rearrangements of the tal-1 locus as clonal markers for T cell acute lymphoblastic leukemia" . J. Clin. Invest . 87 (6): 2029–35. doi :10.1172/JCI115232 . PMC 296958 . PMID 2040693 .
Aplan PD, Lombardi DP, Ginsberg AM, et al. (1991). "Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity" . Science . 250 (4986): 1426–9. doi :10.1126/science.2255914 . PMID 2255914 .
Kikuchi A, Hayashi Y, Kobayashi S, et al. (1993). "Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma". Leukemia . 7 (7): 933–8. PMID 8321044 .
Collazo-Garcia N, Scherer P, Aplan PD (1997). "Cloning and characterization of a murine SIL gene". Genomics . 30 (3): 506–13. doi :10.1006/geno.1995.1271 . PMID 8825637 .
Izraeli S, Colaizzo-Anas T, Bertness VL, et al. (1997). "Expression of the SIL gene is correlated with growth induction and cellular proliferation". Cell Growth Differ . 8 (11): 1171–9. PMID 9372240 .
Göttgens B, Barton LM, Gilbert JG, et al. (2000). "Analysis of vertebrate SCL loci identifies conserved enhancers" . Nat. Biotechnol . 18 (2): 181–6. doi :10.1038/72635 . PMID 10657125 . S2CID 27473560 .
Raghavan SC, Kirsch IR, Lieber MR (2001). "Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints" . J. Biol. Chem . 276 (31): 29126–33. doi :10.1074/jbc.M103797200 . PMID 11390401 .
Carlotti E, Pettenella F, Amaru R, et al. (2002). "Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia" . Br. J. Haematol . 118 (4): 1011–8. doi :10.1046/j.1365-2141.2002.03747.x . PMID 12199779 . S2CID 20462278 .
Karkera JD, Izraeli S, Roessler E, et al. (2003). "The genomic structure, chromosomal localization, and analysis of SIL as a candidate gene for holoprosencephaly" . Cytogenet. Genome Res . 97 (1–2): 62–7. doi :10.1159/000064057 . PMID 12438740 . S2CID 33129304 .
Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences" . Proc. Natl. Acad. Sci. U.S.A . 99 (26): 16899–903. doi :10.1073/pnas.242603899 . PMC 139241 . PMID 12477932 .
Colaizzo-Anas T, Aplan PD (2003). "Cloning and characterization of the SIL promoter". Biochim. Biophys. Acta . 1625 (2): 207–13. doi :10.1016/S0167-4781(02)00597-3 . PMID 12531481 .
Curry JD, Smith MT (2003). "Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR". Leuk. Res . 27 (7): 575–82. doi :10.1016/S0145-2126(02)00260-6 . PMID 12681356 .
Cavé H, Suciu S, Preudhomme C, et al. (2004). "Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951" . Blood . 103 (2): 442–50. doi :10.1182/blood-2003-05-1495 . PMID 14504110 .
Erez A, Perelman M, Hewitt SM, et al. (2004). "Sil overexpression in lung cancer characterizes tumors with increased mitotic activity" . Oncogene . 23 (31): 5371–7. doi :10.1038/sj.onc.1207685 . PMID 15107824 .
Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)" . Genome Res . 14 (10B): 2121–7. doi :10.1101/gr.2596504 . PMC 528928 . PMID 15489334 .
Campaner S, Kaldis P, Izraeli S, Kirsch IR (2005). "Sil Phosphorylation in a Pin1 Binding Domain Affects the Duration of the Spindle Checkpoint" . Mol. Cell. Biol . 25 (15): 6660–72. doi :10.1128/MCB.25.15.6660-6672.2005 . PMC 1190358 . PMID 16024801 .
Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). "Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes" . Genome Res . 16 (1): 55–65. doi :10.1101/gr.4039406 . PMC 1356129 . PMID 16344560 .
Kumar A, Girimaji SC, Duvvari MR, Blanton SH (2009): Mutations in STIL,
encoding a pericentriolar and centrosomal protein, cause primary microcephaly. American Journal of Human Genetics 84:286-290.